| UNC-0642 |
2-(4,4-二氟-1-哌啶基)-6-甲氧基-N-[1-异丙基-4-哌啶基]-7-[3-(1-吡咯烷基)丙氧基]-4-喹唑啉胺 |
1481677-78-4 |
| 2-Isopropoxy-N-(2-(3-(trifluoromethylsulfonyl)phenylcarbamoyl)phenyl)benzamide |
2-Isopropoxy-N-(2-(3-(trifluoromethylsulfonyl)phenylcarbamoyl)phenyl)benzamide |
1482500-76-4 |
| fulacimstat(BAY1142524) |
CS-2859 |
1488354-15-9 |
| Adomeglivant |
1488363-78-5 |
1488363-78-5 |
| HUHS015 |
HUHS015 |
1453097-13-6 |
| ASP5878 |
ASP-5878 |
1453208-66-6 |
| GDC-0994 |
GDC-0994 |
1453848-26-4 |
| LDC4297 |
CS-2539 |
1453834-21-3 |
| Rovazolac |
乙基2-[5-[3'-(甲基磺酰基)联苯基-4-基]-3-(三氟甲基)-1H-吡唑-1-基]乙酸酯 |
1454288-88-0 |
| LP-935509 |
化合物LP-935509 |
1454555-29-3 |
| PU-WS13 |
6-氨基-8-[(3,5-二氯苯基)硫基]-N-异丙基-9H-嘌呤-9-丙胺 |
1454619-14-7 |
| N-((4,5-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine |
SR-3029 |
1454585-06-8 |
| LY-3009120 |
LY-3009120 |
1454682-72-4 |
| Lorlatinib (PF-06463922) |
劳拉替尼 |
1454846-35-5 |
| JG98 |
3-苄基-2-((Z)-((E)-5-(6-氯-3-甲基苯并[D]噻唑-2(3H)-亚基)-3-乙基-4- 氧代噻唑啉 -2-亚基)甲基)噻唑-3-鎓氯化物 |
1456551-16-8 |
| SH-4-54 |
SH-4-54 |
1456632-40-8 |
| SH5-07 |
1456632-41-9 |
1456632-41-9 |
| HG-9-91-01 |
N-(2,4-二甲氧基苯基)-N'-(2,6-二甲基苯基)-N-[6-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]脲 |
1456858-58-4 |
| G-749 |
G-749 |
1457983-28-6 |
| SUCRALOSE-D6 |
SUCRALOSE-D6 标准品 |
1459161-55-7 |
QQ
